Mederi Therapeutics, Inc., manufacturers of Stretta Therapy for GERD, today announced that a new study, published in Managed Care, suggests the potential for substantial payer cost savings associated with radiofrequency energy (RFE) treatment of GERD patients, as compared to treatment with medical management or fundoplication.

Stretta clinical data presented at DDW2016 shows effectiveness in challenging GERD patient populations: Obese patients, laryngopharyngeal reflux (LPR) symptoms, GERD post-nissen. DDW activities also included the launch of the new Stretta RFT3 system and four presentations by international Stretta expert physicians.

Mederi Therapeutics today announced a new multi-center registry that will study the benefit of Stretta Therapy as a treatment option in patients who experience gastroesophageal reflux disease (GERD) after sleeve gastrectomy (SG).

Get #GERDSmart! It's time to Get Smart About GERD and help spread the word about the link between chronic reflux and Esophageal Cancer!

Stretta Therapy, a non-ablative radiofrequency treatment for GERD, was called "effective, safe and durable following 15 years of worldwide use" and cited as a "viable complement or alternative to medical and surgical treatment" in a newly-published clinical review of endoscopic techniques for gastroesophageal reflux disease (GERD). Authors Wai-Kit Lo, MD, MPH and Hiroshi Mashimo, MD, PhD of Harvard Medical School, examined multiple alternatives to PPI therapy or surgery, including Stretta and other devices such as endoscopic plication and suturing, as well as injectable and implantable bulking agents. Their findings have been published in the Journal of Clinical Gastroenterology.

GERD Awareness Week reinforces the need for patient education and encourages those suffering to determine whether their reflux is diet related or is a chronic condition, as well as to explore treatment options. The results of a survey of U.S. gastroenterologists revealed that physicians see more patients complaining of reflux during the holidays. Appropriately, GERD Awareness Week 2015 kicks off the holiday season, Thanksgiving week – November 22-28.

Major medical congresses this fall showcased the role of Stretta in the treatment of gastroesophageal reflux disease (GERD). Sessions featuring Stretta were part of the educational programs at Obesity Week, the International Federation for Surgery of Obesity (IFSO), American College of Surgeons (ACS), and the World Organization for Specialized Studies on Diseases of the Esophagus (OESO).

Learn how to perform Stretta, how Stretta can help manage GERD in multiple patient profiles - especially those with GERD after bariatric surgery, and get the latest Stretta data. In addition to the scientific sessions - be sure to visit Mederi booth 1341 in the ACS exhibit hall. Read more for detailed information on schedule and location of scientific sessions.

Mederi has some great events, courses and medical meetings lined up for the fall - we look forward to seeing you anywhere from Los Angeles to Monaco!! Connect with us on twitter @StrettaTherapy or @MederiNews for the latest updates.